Ignite Creation Date:
2024-05-06 @ 1:48 PM
Last Modification Date:
2024-10-26 @ 1:20 PM
Study NCT ID:
NCT04136366
Status:
COMPLETED
Last Update Posted:
2023-06-02
First Post:
2019-10-21
Brief Title:
The GUARD Trial - Part 1 A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy
Sponsor:
Aldeyra Therapeutics Inc
Organization:
Aldeyra Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-14
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-21
First Submit QC Date:
October 21 2019
Study First Post Date:
2019-10-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2023-05-31
Disp First Submit QC Date:
May 31 2023
Disp First Post Date:
2023-06-02
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-05-31
Last Update Post Date:
2023-06-02
Last Update Post Date Type:
ACTUAL